Several research methods were used, ranging from case and literature studies aimed at data gathering, to comparative and graphical analysis, discussion, and finally, the synthesis and critical analysis in the concluding part.
In addition, the current data can contribute significantly to comparative genomics in general and gene expression and regulation among different mouse tissues.
A number of previous studies successfully used claims data to assess comparative effectiveness of DMARDs on specific outcomes [ 6, 7], but not so much research has been done to compare the effectiveness of DMARDs in RA activity.
Many publications use sets of data to present comparative studies.
Microsatellite markers from the genetic map were used to check the validity of the RH map and additional markers were developed from chicken EST data to yield comparative mapping data.
Hospitals submitting data to the Comparative Database sign a data use agreement that allows their de-identified data to be made available for health care research purposes so no additional permissions from the hospitals were required for this analysis.
Several approaches have been used for meta-analysis of microarray data to enable comparative analyses across multiple datasets, to minimize noise and to generate multivariate metrics for clinical use.
Heat flux data were compared to comparative pressure measurement, thermocouple readings, and Karl Fischer titration as current state of the art monitoring techniques.
Thus, there is not sufficient data to do the comparative analysis suggested by the reviewer.
As this was a single-arm study with limited data to interpret, a comparative study to verify the efficacy of vorinostat is warranted.
